These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 38542836)

  • 1. The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis.
    Tang X; Leng M; Tang W; Cai Z; Yang L; Wang L; Zhang Y; Guo J
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes.
    Aghabozorgi AS; Ahangari N; Eftekhaari TE; Torbati PN; Bahiraee A; Ebrahimi R; Pasdar A
    J Cell Physiol; 2019 Dec; 234(12):21796-21809. PubMed ID: 31273798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and Roles of Exosomes in Cardiovascular Disease.
    Zhang Y; Hu YW; Zheng L; Wang Q
    DNA Cell Biol; 2017 Mar; 36(3):202-211. PubMed ID: 28112546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel therapeutic strategy for alleviating atrial remodeling by targeting exosomal miRNAs in atrial fibrillation.
    Hao H; Dai C; Han X; Li Y
    Biochim Biophys Acta Mol Cell Res; 2022 Dec; 1869(12):119365. PubMed ID: 36167158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes and exosomal miRNAs in cardiovascular protection and repair.
    Emanueli C; Shearn AI; Angelini GD; Sahoo S
    Vascul Pharmacol; 2015 Aug; 71():24-30. PubMed ID: 25869502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation.
    Hao H; Yan S; Zhao X; Han X; Fang N; Zhang Y; Dai C; Li W; Yu H; Gao Y; Wang D; Gao Q; Duan Y; Yuan Y; Li Y
    J Transl Med; 2022 Sep; 20(1):407. PubMed ID: 36064558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the Intricate Roles of Exosomes in Cardiovascular Diseases: A Comprehensive Review of Physiological Significance and Pathological Implications.
    Zhang S; Yang Y; Lv X; Liu W; Zhu S; Wang Y; Xu H
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs sequencing of plasma exosomes derived from patients with atrial fibrillation: miR-124-3p promotes cardiac fibroblast activation and proliferation by regulating AXIN1.
    Zhu P; Li H; Zhang A; Li Z; Zhang Y; Ren M; Zhang Y; Hou Y
    J Physiol Biochem; 2022 Feb; 78(1):85-98. PubMed ID: 34495485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes as mediators and biomarkers in fibrosis.
    Qin XJ; Zhang JX; Wang RL
    Biomark Med; 2020 Jun; 14(8):697-712. PubMed ID: 32643390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic and diagnostic role of exosomes in cardiovascular diseases.
    Zamani P; Fereydouni N; Butler AE; Navashenaq JG; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):313-323. PubMed ID: 30385010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNAs in diabetic heart disease.
    Chandrasekera D; Katare R
    Cardiovasc Diabetol; 2022 Jul; 21(1):122. PubMed ID: 35778763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of exosome-derived miRNAs and other contents in adipogenesis.
    Song X; Song Y; Zhang J; Hu Y; Zhang L; Huang Z; Abbas Raza SH; Jiang C; Ma Y; Ma Y; Wu H; Wei D
    Exp Cell Res; 2024 Aug; 441(1):114168. PubMed ID: 39004201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal Micro-RNAs as Intercellular Communicators in Idiopathic Pulmonary Fibrosis.
    Negrete-García MC; de Jesús Ramos-Abundis J; Alvarado-Vasquez N; Montes-Martínez E; Montaño M; Ramos C; Sommer B
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the microRNAs in exosome: A potential therapeutic strategy for alleviation of diabetes-related cardiovascular complication.
    Zhao S; Wang H; Xu H; Tan Y; Zhang C; Zeng Q; Liu L; Qu S
    Pharmacol Res; 2021 Nov; 173():105868. PubMed ID: 34481974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiomyocyte-specific Peli1 contributes to the pressure overload-induced cardiac fibrosis through miR-494-3p-dependent exosomal communication.
    Tang C; Hou YX; Shi PX; Zhu CH; Lu X; Wang XL; Que LL; Zhu GQ; Liu L; Chen Q; Li CF; Xu Y; Li JT; Li YH
    FASEB J; 2023 Jan; 37(1):e22699. PubMed ID: 36520055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Intercellular Communication Mediated by Exosomal ncRNAs in Cardiovascular Disease.
    Zhang X; Sun S; Ren G; Liu W; Chen H
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of exosomes and exosomal microRNA in diabetic cardiomyopathy.
    Gao S; Dong Y; Yan C; Yu T; Cao H
    Front Endocrinol (Lausanne); 2023; 14():1327495. PubMed ID: 38283742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the role of pericardial miRNAs and exosomes in modulating cardiac fibrosis.
    Schoettler FI; Fatehi Hassanabad A; Jadli AS; Patel VB; Fedak PWM
    Cardiovasc Pathol; 2024; 73():107671. PubMed ID: 38906439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic Exosome-Derived microRNAs: Emerging Roles in Cardiovascular Disease.
    Zhang TR; Huang WQ
    J Cardiovasc Transl Res; 2021 Oct; 14(5):824-840. PubMed ID: 33104961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.